The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Breast Biopsy-Global Market Insights and Sales Trends 2024
Synopsis
A breast biopsy is the procedure of locating a diseased tissue in the breast and collecting the specimen sample of the area for further examination and diagnosis. Breast biopsies are performed by using minimally invasive biopsy systems, owing to minimal disfigurement and pain. Non-invasive biopsy techniques provide preventive measures that assist physicians in diagnosing and treating high-risk breast cancer. This information prevents the application of chemotherapy in breast cancer, reducing the complexities of chemo-radiations. Vacuum assisted breast biopsy devices (VAB), core needle biopsies and fine needle aspiration biopsy are commonly used to perform biopsy procedures.
The global Breast Biopsy market size is expected to reach US$ 927.2 million by 2029, growing at a CAGR of 8.3% from 2023 to 2029. The market is mainly driven by the significant applications of Breast Biopsy in various end use industries. The expanding demands from the Hospitals, ASC and Research Centers,, are propelling Breast Biopsy market. Needle-Based Biopsy Systems, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Breast Biopsy Needles segment is estimated at % CAGR for the next seven-year period.
Approximately 12% women in the U.S. are likely to develop breast cancer during their lifetime. Factors contributing to rise in breast cancer cases is over consumption of alcoholic drinks, lack of physical exercise, improper diet and eating habits, high level of hormonal imbalance & exposure of skin to intense sunlight. However, limited awareness among female population and substandard healthcare facilities especially in developing regions are the factor restraining the growth of breast biopsy market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Breast Biopsy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Breast Biopsy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Breast Biopsy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Breast Biopsy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Breast Biopsy covered in this report include BD, C.R. Bard, Hologic, Leica Biosystems, Argon Medical Devices, Aurora Imaging, Carestream Health, Cook Medical and Fischer Medical Technologies, etc.
The global Breast Biopsy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BD
C.R. Bard
Hologic
Leica Biosystems
Argon Medical Devices
Aurora Imaging
Carestream Health
Cook Medical
Fischer Medical Technologies
Intact Medical
Internazionale Medico Scientifica
Metaltronica
Sectra
Terason
ZAMAR CARE
Global Breast Biopsy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Breast Biopsy market, Segment by Type:
Needle-Based Biopsy Systems
Breast Biopsy Needles
Biopsy Imaging Guidance Systems
Others
Global Breast Biopsy market, by Application
Hospitals
ASC
Research Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Breast Biopsy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
A breast biopsy is the procedure of locating a diseased tissue in the breast and collecting the specimen sample of the area for further examination and diagnosis. Breast biopsies are performed by using minimally invasive biopsy systems, owing to minimal disfigurement and pain. Non-invasive biopsy techniques provide preventive measures that assist physicians in diagnosing and treating high-risk breast cancer. This information prevents the application of chemotherapy in breast cancer, reducing the complexities of chemo-radiations. Vacuum assisted breast biopsy devices (VAB), core needle biopsies and fine needle aspiration biopsy are commonly used to perform biopsy procedures.
The global Breast Biopsy market size is expected to reach US$ 927.2 million by 2029, growing at a CAGR of 8.3% from 2023 to 2029. The market is mainly driven by the significant applications of Breast Biopsy in various end use industries. The expanding demands from the Hospitals, ASC and Research Centers,, are propelling Breast Biopsy market. Needle-Based Biopsy Systems, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Breast Biopsy Needles segment is estimated at % CAGR for the next seven-year period.
Approximately 12% women in the U.S. are likely to develop breast cancer during their lifetime. Factors contributing to rise in breast cancer cases is over consumption of alcoholic drinks, lack of physical exercise, improper diet and eating habits, high level of hormonal imbalance & exposure of skin to intense sunlight. However, limited awareness among female population and substandard healthcare facilities especially in developing regions are the factor restraining the growth of breast biopsy market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Breast Biopsy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Breast Biopsy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Breast Biopsy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Breast Biopsy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Breast Biopsy covered in this report include BD, C.R. Bard, Hologic, Leica Biosystems, Argon Medical Devices, Aurora Imaging, Carestream Health, Cook Medical and Fischer Medical Technologies, etc.
The global Breast Biopsy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BD
C.R. Bard
Hologic
Leica Biosystems
Argon Medical Devices
Aurora Imaging
Carestream Health
Cook Medical
Fischer Medical Technologies
Intact Medical
Internazionale Medico Scientifica
Metaltronica
Sectra
Terason
ZAMAR CARE
Global Breast Biopsy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Breast Biopsy market, Segment by Type:
Needle-Based Biopsy Systems
Breast Biopsy Needles
Biopsy Imaging Guidance Systems
Others
Global Breast Biopsy market, by Application
Hospitals
ASC
Research Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Breast Biopsy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Breast Biopsy
1.1 Breast Biopsy Market Overview
1.1.1 Breast Biopsy Product Scope
1.1.2 Breast Biopsy Market Status and Outlook
1.2 Global Breast Biopsy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Breast Biopsy Market Size by Region (2018-2029)
1.4 Global Breast Biopsy Historic Market Size by Region (2018-2023)
1.5 Global Breast Biopsy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Breast Biopsy Market Size (2018-2029)
1.6.1 North America Breast Biopsy Market Size (2018-2029)
1.6.2 Europe Breast Biopsy Market Size (2018-2029)
1.6.3 Asia-Pacific Breast Biopsy Market Size (2018-2029)
1.6.4 Latin America Breast Biopsy Market Size (2018-2029)
1.6.5 Middle East & Africa Breast Biopsy Market Size (2018-2029)
2 Breast Biopsy Market by Type
2.1 Introduction
2.1.1 Needle-Based Biopsy Systems
2.1.2 Breast Biopsy Needles
2.1.3 Biopsy Imaging Guidance Systems
2.1.4 Others
2.2 Global Breast Biopsy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Breast Biopsy Historic Market Size by Type (2018-2023)
2.2.2 Global Breast Biopsy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Breast Biopsy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Breast Biopsy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Breast Biopsy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Breast Biopsy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Breast Biopsy Revenue Breakdown by Type (2018-2029)
3 Breast Biopsy Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 ASC
3.1.3 Research Centers
3.2 Global Breast Biopsy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Breast Biopsy Historic Market Size by Application (2018-2023)
3.2.2 Global Breast Biopsy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Breast Biopsy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Breast Biopsy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Breast Biopsy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Breast Biopsy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Breast Biopsy Revenue Breakdown by Application (2018-2029)
4 Breast Biopsy Competition Analysis by Players
4.1 Global Breast Biopsy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Breast Biopsy as of 2022)
4.3 Date of Key Players Enter into Breast Biopsy Market
4.4 Global Top Players Breast Biopsy Headquarters and Area Served
4.5 Key Players Breast Biopsy Product Solution and Service
4.6 Competitive Status
4.6.1 Breast Biopsy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 BD
5.1.1 BD Profile
5.1.2 BD Main Business
5.1.3 BD Breast Biopsy Products, Services and Solutions
5.1.4 BD Breast Biopsy Revenue (US$ Million) & (2018-2023)
5.1.5 BD Recent Developments
5.2 C.R. Bard
5.2.1 C.R. Bard Profile
5.2.2 C.R. Bard Main Business
5.2.3 C.R. Bard Breast Biopsy Products, Services and Solutions
5.2.4 C.R. Bard Breast Biopsy Revenue (US$ Million) & (2018-2023)
5.2.5 C.R. Bard Recent Developments
5.3 Hologic
5.3.1 Hologic Profile
5.3.2 Hologic Main Business
5.3.3 Hologic Breast Biopsy Products, Services and Solutions
5.3.4 Hologic Breast Biopsy Revenue (US$ Million) & (2018-2023)
5.3.5 Leica Biosystems Recent Developments
5.4 Leica Biosystems
5.4.1 Leica Biosystems Profile
5.4.2 Leica Biosystems Main Business
5.4.3 Leica Biosystems Breast Biopsy Products, Services and Solutions
5.4.4 Leica Biosystems Breast Biopsy Revenue (US$ Million) & (2018-2023)
5.4.5 Leica Biosystems Recent Developments
5.5 Argon Medical Devices
5.5.1 Argon Medical Devices Profile
5.5.2 Argon Medical Devices Main Business
5.5.3 Argon Medical Devices Breast Biopsy Products, Services and Solutions
5.5.4 Argon Medical Devices Breast Biopsy Revenue (US$ Million) & (2018-2023)
5.5.5 Argon Medical Devices Recent Developments
5.6 Aurora Imaging
5.6.1 Aurora Imaging Profile
5.6.2 Aurora Imaging Main Business
5.6.3 Aurora Imaging Breast Biopsy Products, Services and Solutions
5.6.4 Aurora Imaging Breast Biopsy Revenue (US$ Million) & (2018-2023)
5.6.5 Aurora Imaging Recent Developments
5.7 Carestream Health
5.7.1 Carestream Health Profile
5.7.2 Carestream Health Main Business
5.7.3 Carestream Health Breast Biopsy Products, Services and Solutions
5.7.4 Carestream Health Breast Biopsy Revenue (US$ Million) & (2018-2023)
5.7.5 Carestream Health Recent Developments
5.8 Cook Medical
5.8.1 Cook Medical Profile
5.8.2 Cook Medical Main Business
5.8.3 Cook Medical Breast Biopsy Products, Services and Solutions
5.8.4 Cook Medical Breast Biopsy Revenue (US$ Million) & (2018-2023)
5.8.5 Cook Medical Recent Developments
5.9 Fischer Medical Technologies
5.9.1 Fischer Medical Technologies Profile
5.9.2 Fischer Medical Technologies Main Business
5.9.3 Fischer Medical Technologies Breast Biopsy Products, Services and Solutions
5.9.4 Fischer Medical Technologies Breast Biopsy Revenue (US$ Million) & (2018-2023)
5.9.5 Fischer Medical Technologies Recent Developments
5.10 Intact Medical
5.10.1 Intact Medical Profile
5.10.2 Intact Medical Main Business
5.10.3 Intact Medical Breast Biopsy Products, Services and Solutions
5.10.4 Intact Medical Breast Biopsy Revenue (US$ Million) & (2018-2023)
5.10.5 Intact Medical Recent Developments
5.11 Internazionale Medico Scientifica
5.11.1 Internazionale Medico Scientifica Profile
5.11.2 Internazionale Medico Scientifica Main Business
5.11.3 Internazionale Medico Scientifica Breast Biopsy Products, Services and Solutions
5.11.4 Internazionale Medico Scientifica Breast Biopsy Revenue (US$ Million) & (2018-2023)
5.11.5 Internazionale Medico Scientifica Recent Developments
5.12 Metaltronica
5.12.1 Metaltronica Profile
5.12.2 Metaltronica Main Business
5.12.3 Metaltronica Breast Biopsy Products, Services and Solutions
5.12.4 Metaltronica Breast Biopsy Revenue (US$ Million) & (2018-2023)
5.12.5 Metaltronica Recent Developments
5.13 Sectra
5.13.1 Sectra Profile
5.13.2 Sectra Main Business
5.13.3 Sectra Breast Biopsy Products, Services and Solutions
5.13.4 Sectra Breast Biopsy Revenue (US$ Million) & (2018-2023)
5.13.5 Sectra Recent Developments
5.14 Terason
5.14.1 Terason Profile
5.14.2 Terason Main Business
5.14.3 Terason Breast Biopsy Products, Services and Solutions
5.14.4 Terason Breast Biopsy Revenue (US$ Million) & (2018-2023)
5.14.5 Terason Recent Developments
5.15 ZAMAR CARE
5.15.1 ZAMAR CARE Profile
5.15.2 ZAMAR CARE Main Business
5.15.3 ZAMAR CARE Breast Biopsy Products, Services and Solutions
5.15.4 ZAMAR CARE Breast Biopsy Revenue (US$ Million) & (2018-2023)
5.15.5 ZAMAR CARE Recent Developments
6 North America
6.1 North America Breast Biopsy Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Breast Biopsy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Breast Biopsy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Breast Biopsy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Breast Biopsy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Breast Biopsy Market Dynamics
11.1 Breast Biopsy Industry Trends
11.2 Breast Biopsy Market Drivers
11.3 Breast Biopsy Market Challenges
11.4 Breast Biopsy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
